An Exploratory Investigation of International Pharmaceutical Firms' FDI Decision into China: A Comparison Between Eastern Firms and Western Firms

Fuming Jiang

    Research output: Contribution to journalArticle

    Abstract

    This paper investigated the determinants of international pharmaceutical firms' foreign direct investment (FDI) into the Chinese pharmaceutical manufacturing industry during the period from 1980 to 1998. The analysis of 43 cases showed that international pharmaceutical firms' FDI into China were predominantly driven by China's specific location factors. China's market size with its great potential played the most important role. China's rapid economic development & growth and its open-door policy were other two important determinants. Relative stable political conditions and incentive policies provided by China were also considered as important factors. The impact of relatively stable political conditions in China on western pharmaceutical firms' FDI into China was significantly greater that that on eastern firms'. Incentive policies provided by China received more attention from eastern firms.
    Original languageEnglish
    Pages (from-to)185-192
    Number of pages8
    JournalThe Journal of Academy of Business and Economics
    Volume1
    Issue number1
    Publication statusPublished - 2003

    Fingerprint Dive into the research topics of 'An Exploratory Investigation of International Pharmaceutical Firms' FDI Decision into China: A Comparison Between Eastern Firms and Western Firms'. Together they form a unique fingerprint.

  • Cite this